>
pdufa.bio

NOV-002

Updated ยทnext FDA decision on the calendar

NOV-002 is a Cellectar Biosciences, Inc. program. Every date links its source.

CLRB catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Cellectar Biosciences, Inc. (CLRB). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Aug 2026CLRB

Questions

When is NOV-002's next FDA decision or readout?

No upcoming catalyst is on our calendar for NOV-002; no FDA decisions are on record below.

What happened at NOV-002's most recent FDA decision?

No FDA decision for NOV-002 is in our archive yet.

Who makes NOV-002?

Cellectar Biosciences, Inc. (CLRB).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.